A Micro and Macro Analysis of Israel\u27s Organ Donation System

From the Washington University Office of Undergraduate Research Digest (WUURD), Vol. 12, 05-01-2017. Published by the Office of Undergraduate Research. Joy Zalis Kiefer, Director of Undergraduate Research and Associate Dean in the College of Arts & Sciences; Lindsey Paunovich, Editor; Helen Human, Programs Manager and Assistant Dean in the College of Arts and Sciences Mentor: Charlie Kurt

9 Horses

Center for the Performing Arts November 8, 2017 Wednesday Evening 7:00p.m

Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years

Alemtuzumab; Efficacy; SafetyAlemtuzumab; Eficacia; SeguridadAlemtuzumab; Eficàcia; SeguretatBackground Alemtuzumab significantly improved clinical and MRI outcomes vs. subcutaneous interferon beta-1a (SC IFNB-1a) in the CARE-MS trials (NCT00530348, NCT00548405), with sustained efficacy in 2 consecutive extensions (NCT00930553, NCT02255656 [TOPAZ]). Methods Post hoc analysis of 8-year alemtuzumab efficacy and safety in pooled CARE-MS patients (N=811) stratified by baseline age (≥18 to ≤25, >25 to ≤35, >35 to ≤45, >45 to ≤55 years). Results Compared with SC IFNB-1a over 2 years across age cohorts, alemtuzumab lowered annualized relapse rates (ARR; 0.22–0.24 vs. 0.38–0.51), improved or stabilized disability (freedom from 6-month confirmed disability worsening [CDW]: 85%–92% vs. 62%–88%; achievement of 6-month confirmed disability improvement [CDI]: 20%–31% vs. 13%–25%), increased proportions free of MRI disease activity (70%–86% vs. 42%–63% per year), and slowed brain volume loss (BVL; –0.45% to –0.87% vs. –0.50% to –1.39%). Through Year 2, the treatment effect with alemtuzumab did not significantly differ among age groups for ARR (p-interaction=0.6325), 6-month CDW-free (p-interaction=0.4959), 6-month CDI (p-interaction=0.9268), MRI disease activity-free (p-interaction=0.6512), and BVL (p-interaction=0.4970). Alemtuzumab remained effective on outcomes through Year 8 across age groups. Age-related increases in malignancies (≤45 years: 0.9%–2.2% vs. >45 years: 8.1%) and deaths (0%–1.7% vs. 7.0%) were observed. Serious infections also increased from the youngest (5.1%) to oldest (12.8%) age cohorts. Conclusions Alemtuzumab had greater efficacy than SC IFNB-1a over 2 years across comparable age groups, with no significant differences between alemtuzumab-treated age groups. Efficacy on relapse, disability, and MRI outcomes continued through Year 8 across age groups. Age-related increases in serious infections, malignancies, and deaths were observed.The study was supported by Sanofi and Bayer HealthCare Pharmaceuticals

Movement Interventions for Children with Autism and Developmental Disabilities: An Evidence-Based Practice Project

This review explored the following question: Are the comprehensive treatment models Makoto Therapy, Brain Gym, and Interactive Metronome effective interventions for improving occupational performance including improving executive function, academic performance, and physical coordination in children and adolescents with Autism Spectrum Disorder (ASD)? Because current research on Interactive Metronome, Brain Gym®, and Makoto Therapy fails to address children and adolescents with autism spectrum disorder, presents multiple flaws in research design, and does not measure occupational outcomes such as occupational performance, we recommend that these interventions should not be used as comprehensive treatment models in occupational therapy. We recommend that more occupational-based, methodologically-sound research involving youth with ASD be conducted before implementing these interventions in occupational therapy practice

Challenges in implementing The Institute of Medicine systematic review standards

Abstract: In 2011, The Institute of Medicine (IOM) identified a set of methodological standards to improve the validity, trustworthiness, and usefulness of systematic reviews. These standards, based on a mix of theoretical principles, empiric evidence, and commonly considered best practices, set a high bar for authors of systematic reviews. Based on over 15 years of experience conducting systematic reviews, the Agency for Healthcare Research and Quality Evidence-based Practice Center (EPC) program has examined the EPC’s adherence and agreement with the IOM standards. Even such a large program, with infrastructure and resource support, found challenges in implementing all of the IOM standards. We summarize some of the challenges in implementing the IOM standards as a whole and suggest some considerations for individual or smaller research groups needing to prioritize which standards to adhere to, yet still achieve the highest quality and utility possible for their systematic reviews

APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma

APOBEC is a mutagenic source in human papillomavirus (HPV)-mediated malignancies, including HPV+ oropharyngeal squamous cell carcinoma (HPV + OPSCC), and in HPV genomes. It is unknown why APOBEC mutations predominate in HPV + OPSCC, or if the APOBEC-induced mutations observed in both human cancers and HPV genomes are directly linked. We performed sequencing of host somatic exomes, transcriptomes, and HPV16 genomes from 79 HPV + OPSCC samples, quantifying APOBEC mutational burden and activity in both host and virus. APOBEC was the dominant mutational signature in somatic exomes. In viral genomes, there was a mean of five (range 0–29) mutations per genome. The mean of APOBEC mutations in viral genomes was one (range 0–5). Viral APOBEC mutations, compared to non-APOBEC mutations, were more likely to be low-variant allele fraction mutations, suggesting that APOBEC mutagenesis actively occurrs in viral genomes during infection. HPV16 APOBEC-induced mutation patterns in OPSCC were similar to those previously observed in cervical samples. Paired host and viral analyses revealed that APOBEC-enriched tumor samples had higher viral APOBEC mutation rates (p = 0.028), and APOBEC-associated RNA editing (p = 0.008), supporting the concept that APOBEC mutagenesis in host and viral genomes is directly linked and occurrs during infection. Using paired sequencing of host somatic exomes, transcriptomes, and viral genomes, we demonstrated for the first-time definitive evidence of concordance between tumor and viral APOBEC mutagenesis. This finding provides a missing link connecting APOBEC mutagenesis in host and virus and supports a common mechanism driving APOBEC dysregulation

Evaluating Four Inosine-Uridine Preferring Nucleoside Hydrolases in Bacillus Anthracis for Decontamination Strategies

Andrew Roser­ is a doctoral student in the School of Biological Sciences at Louisiana Tech University. Abigail Bass, Sophie Bott, Madison Brewton, Adam Broussard, Taylor Clement, Makenzie Cude, Hunter Currie, Claire Herke, Mary Hickman, Lauren James, Hailey Johnson, Madeline Lechtenberg, Sarah Murchison, Alex Plaisance, Wil Plants, Alex Sullivan, Sara Vandenberg, and Kaitlynn Willis are undergraduate students in the School of Biological Sciences at Louisiana Tech University. Rebecca Giorno is an Associate Professor in the School of Biological Sciences at Louisiana Tech University

A reciclable bifuctional acid-base organocatalyst with ionic liquid character. The role of sites separation and spatial configuration on different condensation reaction

A series of bifunctional organic catalysts containing acid and basic sites with ionic liquid characteristics have been prepared and their catalytic activity and reaction coordinate for aldol and Knoevenagel condensations have been compared. While the only factor controlling catalyst activity for the Knoevenagel condensation was the distance between the acid and base sites, the spatial orientation of the organocatalyst is also key to achieve high activity and selectivity in the Claisen-Schmidt condensation. Mechanistic studies based on theoretical DFT calculations show that the acid-base bifunctional organocatalyst follows a mechanism inspired in natural aldolases for the synthesis of trans-chalcones, being able to produce a large variety of these compounds of industrial interest. The combination of the acid-base pairs within the proper geometry and the ionic liquid nature makes this catalyst active, selective and recyclable.We thank Consolider-Ingenio 2010 (project MULTICAT), Spanish MICINN (Project MAT2006-14274-C02-01), Generalitat Valenciana (Project PROMETEO/2008/130), and Fundacion Areces for financial support.Corma Canós, A.; Boronat Zaragoza, M.; Climent Olmedo, MJ.; Iborra Chornet, S.; Montón Molina, R.; Sabater Picot, MJ. (2011). A reciclable bifuctional acid-base organocatalyst with ionic liquid character. The role of sites separation and spatial configuration on different condensation reaction. Physical Chemistry Chemical Physics. 13(38):17255-17261. https://doi.org/10.1039/c1cp21986cS17255172611338Motokura, K., Tada, M., & Iwasawa, Y. (2008). Acid-Base Bifunctional Catalytic Surfaces for Nucleophilic Addition Reactions. Chemistry - An Asian Journal, 3(8-9), 1230-1236. doi:10.1002/asia.200800126Gröger, H. (2001). The Development of New Monometallic Bifunctional Catalysts with Lewis acidand Lewis Base Properties, and their Application in Asymmetric Cyanation Reactions. Chemistry - A European Journal, 7(24), 5246-5251. doi:10.1002/1521-3765(20011217)7:243.0.co;2-oKanai, M., Kato, N., Ichikawa, E., & Shibasaki, M. (2005). Recent progress in Lewis acid-Lewis base bifunctional asymmetric catalysis. Pure and Applied Chemistry, 77(12), 2047-2052. doi:10.1351/pac200577122047Shen, Y., Feng, X., Li, Y., Zhang, G., & Jiang, Y. (2003). A mild and efficient cyanosilylation of ketones catalyzed by a Lewis acid–Lewis base bifunctional catalyst. Tetrahedron, 59(30), 5667-5675. doi:10.1016/s0040-4020(03)00908-6Kanemasa, S., & Ito, K. (2004). Double Catalytic Activation with Chiral Lewis Acid and Amine Catalysts. European Journal of Organic Chemistry, 2004(23), 4741-4753. doi:10.1002/ejoc.200400277Ma, J.-A., & Cahard, D. (2004). Towards Perfect Catalytic Asymmetric Synthesis: Dual Activation of the Electrophile and the Nucleophile. Angewandte Chemie International Edition, 43(35), 4566-4583. doi:10.1002/anie.200300635Wang, Y., Li, H., Wang, Y.-Q., Liu, Y., Foxman, B. M., & Deng, L. (2007). Asymmetric Diels−Alder Reactions of 2-Pyrones with a Bifunctional Organic Catalyst. Journal of the American Chemical Society, 129(20), 6364-6365. doi:10.1021/ja070859hLin, Y.-M., Boucau, J., Li, Z., Casarotto, V., Lin, J., Nguyen, A. N., & Ehrmantraut, J. (2007). A Lewis Acid−Lewis Base Bifunctional Catalyst from a New Mixed Ligand. Organic Letters, 9(4), 567-570. doi:10.1021/ol0626903Corma, A., Ródenas, T., & Sabater, M. (2010). A Bifunctional Pd/MgO Solid Catalyst for the One-Pot Selective N-Monoalkylation of Amines with Alcohols. Chemistry - A European Journal, 16(1), 254-260. doi:10.1002/chem.200901501Ruiz, V. R., Corma, A., & Sabater, M. J. (2010). New route for the synthesis of benzimidazoles by a one-pot multistep process with mono and bifunctional solid catalysts. Tetrahedron, 66(3), 730-735. doi:10.1016/j.tet.2009.11.048Boronat, M., Climent, M. J., Corma, A., Iborra, S., Montón, R., & Sabater, M. J. (2010). Bifunctional Acid-Base Ionic Liquid Organocatalysts with a Controlled Distance Between Acid and Base Sites. Chemistry - A European Journal, 16(4), 1221-1231. doi:10.1002/chem.200901519Boronat, M., Concepción, P., Corma, A., Navarro, M. T., Renz, M., & Valencia, S. (2009). Reactivity in the confined spaces of zeolites: the interplay between spectroscopy and theory to develop structure–activity relationships for catalysis. Physical Chemistry Chemical Physics, 11(16), 2876. doi:10.1039/b821297jCorma, A., & Renz, M. (2007). A General Method for the Preparation of Ethers Using Water-Resistant Solid Lewis Acids. Angewandte Chemie International Edition, 46(1-2), 298-300. doi:10.1002/anie.200604018Boronat, M., Corma, A., Renz, M., & Viruela, P. M. (2006). Predicting the Activity of Single Isolated Lewis Acid Sites in Solid Catalysts. Chemistry - A European Journal, 12(27), 7067-7077. doi:10.1002/chem.200600478Climent, M. J., Corma, A., De Frutos, P., Iborra, S., Noy, M., Velty, A., & Concepción, P. (2010). Chemicals from biomass: Synthesis of glycerol carbonate by transesterification and carbonylation with urea with hydrotalcite catalysts. The role of acid–base pairs. Journal of Catalysis, 269(1), 140-149. doi:10.1016/j.jcat.2009.11.001Climent, M. J., Corma, A., Iborra, S., Mifsud, M., & Velty, A. (2010). New one-pot multistep process with multifunctional catalysts: decreasing the E factor in the synthesis of fine chemicals. Green Chem., 12(1), 99-107. doi:10.1039/b919660aCorma, A., Iborra, S., & Velty, A. (2007). Chemical Routes for the Transformation of Biomass into Chemicals. Chemical Reviews, 107(6), 2411-2502. doi:10.1021/cr050989dCliment, M. J., Corma, A., & Iborra, S. (2011). Heterogeneous Catalysts for the One-Pot Synthesis of Chemicals and Fine Chemicals. Chemical Reviews, 111(2), 1072-1133. doi:10.1021/cr1002084Koshland, D. E. (1958). Application of a Theory of Enzyme Specificity to Protein Synthesis. Proceedings of the National Academy of Sciences, 44(2), 98-104. doi:10.1073/pnas.44.2.98Bass, J. D., Solovyov, A., Pascall, A. J., & Katz, A. (2006). Acid−Base Bifunctional and Dielectric Outer-Sphere Effects in Heterogeneous Catalysis:  A Comparative Investigation of Model Primary Amine Catalysts. Journal of the American Chemical Society, 128(11), 3737-3747. doi:10.1021/ja057395cVasella, A., Davies, G. J., & Böhm, M. (2002). Glycosidase mechanisms. Current Opinion in Chemical Biology, 6(5), 619-629. doi:10.1016/s1367-5931(02)00380-0Drexler, M. (2003). The effect of solvents on the heterogeneous synthesis of flavanone over MgO. Journal of Catalysis, 214(1), 136-145. doi:10.1016/s0021-9517(02)00013-1Fuentes, A., Marinas, J. M., & Sinisterra, J. V. (1987). Catalyzed synthesis of chalcones under interfacial solid-liquid conditions with ultrasound. Tetrahedron Letters, 28(39), 4541-4544. doi:10.1016/s0040-4039(00)96558-4Climent, M. ., Corma, A., Iborra, S., & Velty, A. (2004). Activated hydrotalcites as catalysts for the synthesis of chalcones of pharmaceutical interest. Journal of Catalysis, 221(2), 474-482. doi:10.1016/j.jcat.2003.09.012Shen, J., Wang, H., Liu, H., Sun, Y., & Liu, Z. (2008). Brønsted acidic ionic liquids as dual catalyst and solvent for environmentally friendly synthesis of chalcone. Journal of Molecular Catalysis A: Chemical, 280(1-2), 24-28. doi:10.1016/j.molcata.2007.10.021Ballesteros, J. F., Sanz, M. J., Ubeda, A., Miranda, M. A., Iborra, S., Paya, M., & Alcaraz, M. J. (1995). Synthesis and Pharmacological Evaluation of 2’-Hydroxychalcones and Flavones as Inhibitors of Inflammatory Mediators Generation. Journal of Medicinal Chemistry, 38(14), 2794-2797. doi:10.1021/jm00014a032Yit, C. C., & Das, N. P. (1994). Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Letters, 82(1), 65-72. doi:10.1016/0304-3835(94)90147-3Becke, A. D. (1993). Density‐functional thermochemistry. III. The role of exact exchange. The Journal of Chemical Physics, 98(7), 5648-5652. doi:10.1063/1.464913Perdew, J. P., & Wang, Y. (1992). Accurate and simple analytic representation of the electron-gas correlation energy. Physical Review B, 45(23), 13244-13249. doi:10.1103/physrevb.45.13244Dewar, M. J. S., & Thiel, W. (1977). Ground states of molecules. 39. MNDO results for molecules containing hydrogen, carbon, nitrogen, and oxygen. Journal of the American Chemical Society, 99(15), 4907-4917. doi:10.1021/ja00457a005Davis, L. P., Guidry, R. M., Williams, J. R., Dewar, M. J. S., & Rzepa, H. S. (1981). MNDO calculations for compounds containing aluminum and boron. Journal of Computational Chemistry, 2(4), 433-445. doi:10.1002/jcc.540020412Hill, H. A. O., Lobb, R. R., Sharp, S. L., Stokes, A. M., Harris, J. I., & Jack, R. S. (1976). Metal-replacement studies in Bacillus stearothermophilus aldolase and a comparison of the mechanisms of class I and class II aldolases. Biochemical Journal, 153(3), 551-560. doi:10.1042/bj153055